Every 8-K that HilleVax, Inc. (HLVX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow HLVX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLVX filings page.
HilleVax, Inc. filed an 8-K reporting material transaction documents tied to a pending merger and related rights. The company incorporated by reference an Agreement and Plan of Merger dated August 4, 2025 involving XOMA Royalty Corporation and XRA 4 Corp. The filing also discloses a Contingent Value Rights (CVR) Agreement dated September 17, 2025, which creates a non-transferable CVR for each share that may pay a cash amount if specified conditions are met. The company filed a Second Amended and Restated Certificate of Incorporation and Second Amended and Restated Bylaws, and referenced retention cash bonuses and other listed exhibits.
HilleVax, Inc. filed a Form 8-K to report the results of its 23 June 2025 Annual Meeting of Stockholders. Two routine governance items were presented:
- Election of three Class III directors – Robert Hershberg, Jeryl Hilleman and Aditya Kohli were each re-elected for three-year terms, receiving roughly 22.0-22.4 million votes for and 1.5-1.8 million votes withheld; 14.5 million broker non-votes were recorded.
- Ratification of auditor – Ernst & Young LLP was confirmed as the Company’s independent registered public accounting firm for fiscal 2025 with 38.24 million votes for, 0.13 million against and 8,105 abstentions.
No other business or financial information was disclosed. The filing indicates normal, uncontested corporate governance with shareholder support for both board composition and external audit appointment.